Europe In-vitro Diagnostics Enzymes Market Size & Outlook
Europe in-vitro diagnostics enzymes market, 2018-2030 (US$M)
Europe in-vitro diagnostics enzymes market highlights
- The Europe in-vitro diagnostics enzymes market generated a revenue of USD 428.8 million in 2024.
- The market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
- In terms of segment, polymerase & transcriptase was the largest revenue generating enzyme in 2024.
- Proteases is the most lucrative enzyme segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 428.8 million |
| Market revenue in 2030 | USD 731.0 million |
| Growth rate | 9.3% (CAGR from 2025 to 2030) |
| Largest segment | Polymerase & transcriptase |
| Fastest growing segment | Proteases |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proteases, Polymerase & Transcriptase, Ribonuclease |
| Key market players worldwide | Biocatalysts Ltd, Merck KGaA, Codexis Inc, Roche Holding AG, Amano Enzyme, Advanced Enzymes, Amicogen, Dyadic International Inc, BBI Solutions, Affymetrix, American Laboratories, Inc. |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.2% of the global in-vitro diagnostics enzymes market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 724.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Diagnostics Enzymes Market Scope
In-vitro Diagnostics Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe in-vitro diagnostics enzymes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Polymerase & transcriptase was the largest segment with a revenue share of 42.33% in 2024. Horizon Databook has segmented the Europe in-vitro diagnostics enzymes market based on proteases, polymerase & transcriptase, ribonuclease covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of a well-established IVD market in many European countries including Germany, France, the UK, Italy, & Spain is one of the key factors for increased adoption and demand for IVD enzymes in the region.
According to the German Diagnostics Industry Association (VDGH), Germany accounts for the largest IVD market in Europe. VDGH also states that Germany is home to more than 150 manufacturers of reagents and systems for IVD use and 74% of the German diagnostics companies conduct R&D & manufacturing within the country.
The European Diagnostic Manufacturers Association (EDMA) reports that molecular diagnostics accounts for the fastest-growing IVD industries in Europe owing to the rise in penetration of techniques such as real-time PCR and next-generation sequencing that facilitate the decoding and amplification of epigenetic & genetic information.
Reasons to subscribe to Europe in-vitro diagnostics enzymes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe in-vitro diagnostics enzymes market databook
-
Our clientele includes a mix of in-vitro diagnostics enzymes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe in-vitro diagnostics enzymes market, including forecasts for subscribers. This continent databook contains high-level insights into Europe in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe in vitro diagnostics enzymes market size, by country, 2018-2030 (US$M)
Europe In-vitro Diagnostics Enzymes Market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
